Q2 2024 · 13F-HR
Sio Capital Management, LLCholdings as filed
Filed 2024-08-14 · accession 0001214659-24-014597
$369.5M
Reported value
48
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $91.3M | 24.7% | 1,362,700 | PUT | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $50.0M | 13.5% | 245,902 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $23.4M | 6.32% | 111,078 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $16.9M | 4.56% | 155,304 | Common | SOLE |
| 83175M205 | SNN | SMITH & NEPHEW PLC | $14.4M | 3.89% | 579,619 | Common | SOLE |
| 695127100 | PCRX | PACIRA BIOSCIENCES INC | $13.0M | 3.53% | 455,500 | PUT | SOLE |
| 68622V106 | OGN | ORGANON & CO | $12.6M | 3.41% | 608,096 | Common | SOLE |
| 37733W204 | GSK | GSK PLC | $12.0M | 3.25% | 312,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $10.2M | 2.76% | 225,165 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $9.9M | 2.67% | 14,764,991 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $9.6M | 2.60% | 600,294 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABORATORIES | $9.3M | 2.52% | 89,500 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $8.9M | 2.40% | 26,786 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $8.8M | 2.39% | 485,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $8.7M | 2.34% | 192,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $6.8M | 1.84% | 2,874,536 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $6.7M | 1.80% | 4,347,855 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $4.6M | 1.26% | 510,267 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $4.6M | 1.24% | 71,740 | Common | SOLE |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $4.4M | 1.19% | 302,710 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $4.4M | 1.19% | 2,708,408 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $4.2M | 1.13% | 491,128 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.2M | 0.86% | 125,174 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.1M | 0.83% | 78,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $2.7M | 0.72% | 1,328,352 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $2.4M | 0.66% | 1,539,352 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.4M | 0.64% | 175,301 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $2.3M | 0.62% | 177,004 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $2.1M | 0.57% | 163,363 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $2.0M | 0.53% | 668,115 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $1.9M | 0.50% | 217,864 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.8M | 0.49% | 778,924 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.8M | 0.48% | 293,417 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.5M | 0.40% | 159,626 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $1.4M | 0.39% | 2,499,800 | Common | SOLE |
| 74065P101 | PRLD | PRELUDE THERAPEUTICS INC | $1.2M | 0.33% | 320,394 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $1.1M | 0.30% | 276,603 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $960,750 | 0.26% | 315,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $891,081 | 0.24% | 71,458 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC. | $699,614 | 0.19% | 121,672 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $627,164 | 0.17% | 162,058 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $397,568 | 0.11% | 133,412 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $354,348 | 0.10% | 50,839 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $206,700 | 0.06% | 130,000 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $76,245 | 0.02% | 254,150 | Common | SOLE |
| 44486Q111 | HUMAW | HUMACYTE INC | $70,497 | 0.02% | 49,998 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $28,880 | 0.01% | 400,000 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $200 | 0.00% | 12,808 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.